Regeneron (REGN) Tops Q2 EPS by $1.17
Tweet
Share
E-mail
Get Alerts REGN Hot Sheet
Price: $805.97 +1.00%
Financial Fact:
Net loss before income tax benefit: 365.88M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Net loss before income tax benefit: 365.88M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Regeneron (NASDAQ: REGN) reported Q2 EPS of $9.77, $1.17 better than the analyst estimate of $8.60. Revenue for the quarter came in at $2.86 billion versus the consensus estimate of $2.79 billion.
For earnings history and earnings-related data on Regeneron (REGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
- Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
